References
[1] Hubbard AK, Spector LG, Fortuna G, Marcotte EL, Poynter JN. Trends in international incidence of pediatric cancers in children under 5 years of Age: 1988–2012.JNCI Cancer Spectr 2019;3:pkz007.https://doi.org/10.1093/jncics/pkz007.
[2] Linabery AM, Ross JA. Trends in childhood cancer incidence in the U.S. (1992–2004). Cancer 2008;112:416-432.https://doi.org/10.1002/cncr.23169.
[3] Yang T, Whitlock RS, Vasudevan SA. Surgical management of hepatoblastoma and recent advances. Cancers (Basel) 2019;11:1944.https://doi.org/10.3390/cancers11121944.
[4] Perilongo G, Shafford E, Maibach R, et al. Risk-adapted treatment for childhood hepatoblastoma. final report of the second study of the International Society of Paediatric Oncology—SIOPEL 2.Eur J Cancer 2004;40:411-421.https://doi.org/10.1016/j.ejca.2003.06.003.
[5] Hiyama E, Hishiki T, Watanabe K, et al. Outcome and late complications of hepatoblastomas treated using the Japanese study group for pediatric liver Tumor 2 protocol. J Clin Oncol 2020;38:2488-2498.https://doi.org/10.1200/JCO.19.01067.
[6] Katzenstein HM, Langham MR, Malogolowkin MH, et al. Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children’s Oncology Group, multicentre, phase 3 trial. Lancet Oncol 2019;20:719-727.https://doi.org/10.1016/S1470-2045(18)30895-7.
[7] Marin JJG, Cives-Losada C, Asensio M, Lozano E, Briz O, Macias RIR. Mechanisms of anticancer drug resistance in hepatoblastoma.Cancers (Basel) 2019;11:407.https://doi.org/10.3390/cancers11030407.
[8] Ortega JA, Douglass EC, Feusner JH, et al. Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children’s Cancer Group and the Pediatric Oncology Group. J Clin Oncol 2000;18:2665-2675.https://doi.org/10.1200/JCO.2000.18.14.2665.
[9] Warmann SW, Fuchs J. Drug resistance in hepatoblastoma.Curr Pharm Biotechnol 2007;8:93-97.https://doi.org/10.2174/138920107780487456.
[10] Meyers RL, Maibach R, Hiyama E, et al. Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children’s Hepatic tumors International Collaboration. Lancet Oncol 2017;18:122-131.https://doi.org/10.1016/S1470-2045(16)30598-8.
[11] Roebuck DJ, Aronson D, Clapuyt P, et al. 2005 PRETEXT: a revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group. Pediatr Radiol 2007;37:123-132; quiz 249-50.https://doi.org/10.1007/s00247-006-0361-5.
[12] Vasudevan SA, Meyers RL, Finegold MJ, et al. Outcomes of children with well-differentiated fetal hepatoblastoma treated with surgery only: report from Children’s Oncology Group Trial, AHEP0731. J Pediatr Surg 2022;57:251-256.https://doi.org/10.1016/j.jpedsurg.2022.05.022.
[13] Saxena R, Leake JL, Shafford EA, et al. Chemotherapy effects on hepatoblastoma. A histological study. Am J Surg Pathol 1993;17:1266-1271.https://doi.org/10.1097/00000478-199312000-00008.
[14] Aronson DC, Weeda VB, Maibach R, et al. Microscopically positive resection margin after hepatoblastoma resection: what is the impact on prognosis? A Childhood Liver Tumours Strategy Group (SIOPEL) report. Eur J Cancer 2019;106:126-132.https://doi.org/10.1016/j.ejca.2018.10.013.
[15] Ren X, Li H, Diao M, Chen L, Xu H, Li L. Results of surgical resections with positive margins for children with hepatoblastoma: case series from a single Asian center. Pediatr Blood Cancer 2019;66:e27479-n/a.https://doi.org/10.1002/pbc.27479.
[16] Heifetz SA, French M, Correa M, Grosfeld JL. Hepatoblastoma: the Indiana experience with preoperative chemotherapy for inoperable tumors; clinicopathological considerations. Pediatr Pathol Lab Med. 1997;17:857-874.
[17] Wang LL, Filippi RZ, Zurakowski D, et al. Effects of neoadjuvant chemotherapy on hepatoblastoma: a morphologic and immunohistochemical study. Am J Surg Pathol 2010;34:287-299.https://doi.org/10.1097/PAS.0b013e3181ce5f1e.
[18] Ren X, Li H, Diao M, Xu H, Li L. Impact of microscopically margin-positive resection on survival in children with hepatoblastoma after hepatectomy: a retrospective cohort study. Int J Clin Oncol 2020;25:765-773.https://doi.org/10.1007/s10147-019-01573-0.
TABLE 1. Children’s hepatic tumors international collaboration—hepatoblastoma stratification